Enzo Biochem, Inc.
Sphingosine pathway modulating compounds for the treatment of cancers
Last updated:
Abstract:
The invention provides methods and compositions for treating cancers and myeloproliferative disorders using sphingosine kinase-1 inhibitors, such as SK1-I, and selective sphingosine-1-phosphate receptor agonists, such as ozanimod.
Status:
Grant
Type:
Utility
Filling date:
8 Apr 2020
Issue date:
5 Jan 2021